Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
02-Sep-2026 | 367 | 376 | 362.1 | 373.05 | 5,466 | 6,55,65,848.4 | 76,533 |
03-Sep-2026 | 373.05 | 376.4 | 368.55 | 374.15 | 1,774 | 2,14,66,009.7 | 31,049 |
04-Sep-2026 | 374 | 398.4 | 373 | 392.5 | 11,260 | 18,42,07,087.8 | 1,91,678 |
07-Sep-2026 | 390 | 444 | 387.45 | 397.95 | 72,833 | 1,62,06,96,208.05 | 8,03,535 |
08-Sep-2026 | 402.7 | 409.4 | 394.15 | 399.15 | 15,389 | 25,40,12,841.5 | 2,58,807 |
09-Sep-2026 | 405 | 417.7 | 402.05 | 407.3 | 16,910 | 21,43,11,722.65 | 1,80,688 |
10-Sep-2026 | 410.55 | 421 | 407 | 417.45 | 16,198 | 23,26,32,918.6 | 2,19,805 |
11-Sep-2026 | 417.85 | 469 | 414.55 | 463.45 | 2,37,234 | 4,71,04,48,446.95 | 15,02,891 |
15-Sep-2026 | 477.95 | 482 | 397.5 | 410.15 | 1,05,763 | 1,81,74,68,387.45 | 12,86,644 |
16-Sep-2026 | 410.2 | 413.35 | 393.25 | 402.95 | 23,718 | 32,26,41,050.75 | 2,01,625 |
17-Sep-2026 | 405.25 | 418.55 | 403.25 | 413.75 | 17,903 | 27,80,74,310.7 | 2,36,113 |
18-Sep-2026 | 415.8 | 446.2 | 415.8 | 442.95 | 54,253 | 76,29,66,916.75 | 5,49,857 |
21-Sep-2026 | 445 | 474.4 | 445 | 466.5 | 52,443 | 1,03,36,72,946.9 | 6,55,605 |
22-Sep-2026 | 467.85 | 494.45 | 467.85 | 483.35 | 41,751 | 92,14,33,801.25 | 6,37,354 |
23-Sep-2026 | 485.8 | 491.9 | 477.3 | 482.95 | 21,604 | 38,85,89,408.95 | 3,28,379 |
24-Sep-2026 | 474.55 | 491 | 471 | 474.05 | 15,200 | 24,53,32,677.85 | 1,97,155 |
25-Sep-2026 | 475.9 | 481.05 | 470 | 475 | 9,977 | 17,20,03,276.15 | 1,39,346 |
28-Sep-2026 | 474.05 | 476 | 460 | 462.15 | 20,699 | 18,11,52,626.3 | 1,88,879 |
29-Sep-2026 | 462 | 482.8 | 453.65 | 479.4 | 17,909 | 28,85,41,371.7 | 2,55,903 |
30-Sep-2026 | 483.9 | 485 | 467.5 | 476.6 | 13,682 | 17,75,68,129.5 | 1,42,451 |
01-Oct-2026 | 473 | 481.9 | 456.35 | 471.3 | 12,363 | 18,48,91,383.15 | 1,67,917 |
SMS Pharma added that it will submit its formal response to the USFDA within the stipulated timeline, in line with standard regulatory practice.
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
